Hazardous Drug (HD) Wipe Sampling
U.S. Micro-Solutions is partnering with Quess360 Pharmacy Solutions to offer targeted HD Wipe Sampling for USP <800> compliance - Safer surfaces, Smarter monitoring!
USP <800> states the following: Environmental wipe sampling for HD surface residue should be performed routinely (e.g., initially as a benchmark and at least every 6 months, or more often as needed, to verify containment).
SOME RECOMMENDED AREAS to be sampled:
- Front grille within the C-PEC
- Cart beside the C-PEC
- Passthrough
- Floor in front of the C-PEC
- Armrest of a patient treatment chair
Build a sampling kit tailored to your needs
| Hormones | Chemo drugs | ||||||
|---|---|---|---|---|---|---|---|
| Select 1, 3 or all 5 | Group 1F | Group 1M | Group 2 | Group 3 | Group 4 | Group 5 | Group 6 |
| Estradiol Estriol Estrone Progesterone Testosterone |
Fluorouracil (5-FU) | Methotrexate | Includes: Cytarabine Dacarbazine DOXOrubicin Epirubicin Gemcitabine Melphalan |
Includes: Cyclophosphamide DOCetaxel Etoposide Ifosfamide Irinotecan Methotrexate PACLitaxel Pemetrexed Topotecan VinBLASTine VinCRIStine |
Includes: CARBOplatin CISplatin Oxaliplatin |
Includes all 21 HDs listed from Group 1F, 1M, 2, 3, 4 | Includes: CARBOplatin CISplatin Cyclophosphamide Fluorouracil Gemcitabine Ifosfamide Methotrexate Oxaliplatin PACLitaxel |
- Contribute to the assessment of safe practices in the workplace
- Evaluate potential HD exposure to staff (pharmacy, nursing, other personnel)
- Validate the effectiveness of decontamination procedures
- Assess the level of compliance of current procedures